Omada Health (NASDAQ:OMDA) Stock Rating Upgraded by Wells Fargo & Company

Omada Health (NASDAQ:OMDA) was upgraded by equities researchers at Wells Fargo & Company to a “hold” rating in a note issued to investors on Thursday,Zacks.com reports.

Other research analysts have also recently issued reports about the stock. BMO Capital Markets started coverage on shares of Omada Health in a report on Thursday, November 13th. They issued an “outperform” rating and a $27.00 target price for the company. The Goldman Sachs Group set a $29.00 price target on shares of Omada Health in a research report on Friday. Morgan Stanley set a $32.00 price objective on shares of Omada Health in a report on Thursday, December 18th. Weiss Ratings reiterated a “sell (d)” rating on shares of Omada Health in a research note on Wednesday, October 8th. Finally, Barclays reduced their target price on Omada Health from $29.00 to $22.00 and set an “overweight” rating for the company in a report on Monday. Eight equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $25.40.

Omada Health Price Performance

OMDA opened at $15.41 on Thursday. The firm has a market cap of $892.39 million and a PE ratio of -61.64. The stock has a 50-day moving average price of $17.60 and a 200-day moving average price of $20.02. Omada Health has a 1 year low of $14.14 and a 1 year high of $28.40.

Insiders Place Their Bets

In related news, President Wei-Li Shao sold 5,618 shares of the firm’s stock in a transaction that occurred on Monday, December 29th. The shares were sold at an average price of $16.13, for a total value of $90,618.34. Following the sale, the president owned 69,079 shares in the company, valued at approximately $1,114,244.27. This trade represents a 7.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Institutional Investors Weigh In On Omada Health

A number of hedge funds have recently added to or reduced their stakes in OMDA. JPMorgan Chase & Co. purchased a new position in shares of Omada Health in the 3rd quarter worth $82,000. Tudor Investment Corp ET AL purchased a new stake in Omada Health during the third quarter valued at $987,000. Wilmington Savings Fund Society FSB bought a new position in Omada Health in the third quarter valued at about $287,000. Dark Forest Capital Management LP purchased a new position in Omada Health in the third quarter worth about $295,000. Finally, Susquehanna International Group LLP bought a new stake in shares of Omada Health during the 3rd quarter valued at about $320,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.